EXHIBITOR &SPONSOR PROSPECTUS 7TH INTERNATIONAL SYMPOSIUM APRIL 20-22, 2017 HOLIDAY INN GOLDEN GATEWAY, SAN FRANCISCO, USA E-mail: [email protected]SPONSORED BY THE SENTINEL NODE ONCOLOGY FOUNDATION www.cancermetastasis.org CANCER M ETASTASIS THROUGH THE LYM PHOVASCULAR SYSTEM : BIOLOGY & TREATM ENT
9
Embed
Cancer Metastasis through the Lymphovascular System: Biology & Treatment, April 20-22, 2017, San Francisco, USA
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
EXHIBITOR & SPONSOR PROSPECTUS
7TH INTERNATIONAL SYMPOSIUMAPRIL 20-22, 2017HOLIDAY INN GOLDEN GATEWAY, SAN FRANCISCO, USA
SPONSORED BY THE SENTINEL NODE ONCOLOGY FOUNDATION
www.cancermetastasis.org
CANCER METASTASIS THROUGH THE LYMPHOVASCULAR SYSTEM:
BIOLOGY & TREATMENT
ABOUT THE CONGRESSSPONSORED BY THE SENTINEL NODE ONCOLOGY FOUNDATION
The Symposium is sponsored by the Sentinel Node Oncology Foundation (SNOF) whose mission is to advance the care and treatment of patients with solid cancer and to help develop new preventative strategies, diagnostics, and treatments. It is now known that the same type of cancer is different from one person to the other. After decades of research, we are poised to enter a new era of medical practice where detailed genetic and other molecular information about a patient's cancer is routinely used to deploy effective, patient-specific reme-dies to treat it. We are about to enter the era of precision medicine (NCI and NIH Precision Medicine Initiative®).
This CME accredited program was developed to provide a forum for discussing and presenting pre-clinical, translational and clinical re-search and thereby improve understanding, diagnosis, treatment, and quality of life of patients suffering from cancer as well as explore emerging diagnostic tools and patient-specific treatments for cancer. Recent developments in understanding the cancer microenviron-ment and the molecular mechanisms involved in the progression of cancer cells to metastasis will be discussed. Participants will acquire knowledge on cutting edge lymphatic system imaging (including sentinel node imaging), lymph/hemangiogenesis, lymphocyte trafficking and late-breaking immunomodulation approaches and the latest innovations in molecular imaging of cancer metastasis. Studies of biomarkers and their diagnostic and prognostic applications in cancer progression and metastatic cancer, as well as their usefulness in ra-dio imaging and molecular targeted therapy will also be significant parts of the Symposium. Promising results of recent clinical trials of emerging therapies including targeted therapy and checkpoint inhibition will be reviewed. Lymphedema, a significant complication of cancer treatment, will be addressed and the current treatment of lymphedema will be updated.
Target Audience: Based on the attendance history we anticipate 350-400 participants, a collegial atmosphere with ample opportunity to network and meet with every attendee with a potential interest in your product or services. These attendees will be primarily physicians (65%) specializing in surgery, oncology, molecular imaging, plastic surgery, radiation oncology, thoracic medicine with the remainder a mix-ture of predominately PhD/scientists from both academia and biotechnology as well as a smaller groups of attendees who are in training, regulatory or from industry.
Virtual Meeting: Most of the Live Presentations will be captured on video with the slide presentations synchronized in a side by side for-mat to be accessible on the cancermetastasis.org website following the live meeting. Please review the program and the information in this prospectus and contact Joan Oefner to discuss your participation. We are happy to customize a sponsorship package based on your com-pany?s specific needs and requirements.
ORGANIZING COMMITTEE: STANLEY P.L. LEONG, MD, SYMPOSIUM CHAIR, California Pacific Medical Center, San Francisco, USA
MICHAEL J. BERNAS, MS, University of Arizona, Tuscon, USA
DALE HAN, MD, Yale School of Medicine, New Haven, USA
DAVE S. B. HOON, PHD, John Wayne Cancer Institute, Santa Monica, USA
MOHAMMED KASHANI-SABET, MD, California Pacific Medical Center, San Francisco, USA
KEVIN KIM, MD, California Pacific Medical Center, San Francisco, USA
DONALD M. MCDONALD, MD, PHD, University of California, San Francisco, USA
DAVID NATHANSON, MD, Henry Ford Health System , Detroit, USA
BARBARA POCKAJ, MD, Mayo Clinic, Phoenix, USA
DOUGLAS S. REINTGEN, MD, University of South Florida, Tampa, USA
SASKIA R.J. THIADENS, RN, San Francisco, USA
RICHARD L. WHITE, JR, MD, Carolinas HealthCare System, Charlotte, USA
MARLYS H. WITTE, MD, University of Arizona, Tuscon, USA
JONATHAN S. ZAGER, MD, Moffitt Cancer Center, Tampa, USA
PRELIMINARY LIST OF CONFIRMED FACULTY
Roy E. Abendroth, MD, California Pacific Medical Center, San Francisco, USA
Athena Aktipis, PhD, Arizona State University, Tempe , USA
Charles M. Balch, MD, University of Texas MD Anderson Cancer Center, Houston, USA
Jai Balkissoon, MD, FACS, PPD, Berkeley, USA
Michael J. Bernas, MS, University of Arizona, Tuscon, USA
Marcus W. Bosenberg, PhD, Yale School of Medicine, New Haven, USA
John K. Chan, MD, California Pacific Medical Center, San Francisco, USA
Michael Dellinger, PhD, UT Southwestern Medical Center, Dallas, USA
Mark B. Faries, MD, John Wayne Cancer Institute, Santa Monica, USA
John V. Frangioni, MD, PhD , The Curadel Companies, Marlborough, USA
Sanjiv Sam Gambhir, MD, PhD, Stanford University School of Medicine, Stanford, USA
Dale Han, MD, Yale School of Medicine, New Haven, USA
Dave S. B. Hoon, PhD, John Wayne Cancer Institute, Santa Monica, USA
Charles C. Hsu, MD, PhD, University of Arizona, Tucson, USA
Mohammed Kashani-Sabet, MD, California Pacific Medical Center, San Francisco, USA
Kevin Kim, MD, California Pacific Medical Ctr, San Francisco, USA
Harriet Kluger, MD, Yale School of Medicine, New Haven, USA
Henry M. Kuerer, MD, PhD, University of Texas MD Anderson Cancer Center, Houston, USA
David Krag, MD, University of Vermont, Burlington, USA
Stanley P.L. Leong, MD, Symposium Chair, California Pacific Medical Ctr, San Francisco, USA
Carlo C. Maley, PhD, Arizona State University, Tempe, USA
Donald M. McDonald, MD, PhD, University of California, San Francisco, USA
Funda Meric-Bernstam, MD, University of Texas MD Anderson Cancer Center, Houston, TX
Nobel Laureate W.E. Moerner, PhD, Stanford University, Stanford, USA
Nicola Mozzillo, MD, National Cancer Institute of Naples, Naples, Italy
S. David Nathanson, MD, Henry Ford Health System , Detroit, USA
Lisa A. Newman, MD, MPH ,Henry Ford Health System, Detroit, USA
David R. Parkinson, MD, Essa Pharmaceuticals, Inc.,Vancouver, Canada
Barbara Pockaj, MD, Mayo Clinic, Phoenix, USA
Douglas S. Reintgen, MD, University of South Florida, Tampa, USA
Hope S. Rugo, MD, University of California San Francisco, San Francisco, USA
Baldassarre Stea, MD, PhD, University of Arizona, Tuscon, USA
Alessandro Testori, MD, Istituto Europeo di Oncologia, Milano, Italy
Saskia R.J. Thiadens, RN, Founder National Lymphedema Network, San Francisco, USA
Mona Wan, MS, MBA, Stanford University, Stanford, USA
Richard L. White, Jr, MD, Carolinas HealthCare System, Charlotte, USA
Marlys H. Witte, MD, University of Arizona, Tuscon, USA
Isaac P. Witz, PhD, Tel Aviv University, Tel Aviv, Israel
Jonathan S. Zager, MD, Moffitt Cancer Center, Tampa, USA
INDUSTRY SUPPORT OPPORTUNITIES
EXHIBIT SPACE: (SPACE IS LIM ITED TO 18 TABLETOPS) - TABLETOP EXHIBIT BOOTH WITH 2 BADGES, $5,000 - TABLETOP EXHIBIT BOOTH WITH 1 BADGE, $4,250 - NON-PROFIT TABLETOP WITH 1 BADGE, $2,500 - LITERATURE ONLY TABLE IN FOYER, $1,500
EXHIBITS INCLUDE ONE 6? X 30? DRAPED TABLE WITH TWO CHAIRS.
Setup of exhibits is on Wednesday, April 19, 2017 from 6:00 ? 10:00 PM and Thursday from 6:00 ? 7:30 AM
GOLD RUSH BALLROOM, HOLIDAY INN GOLDEN GATEWAYOpening for the Industry Sponsored Breakfast Session on Thursday, April 20, 2017, the Exhibits will be open throughout the conference, with peak times during all coffee breaks as well as the Thursday evening e-Poster Session Reception. Industry Sponsored Breakfast & Lunch Sessions will also take place in the Exhibit Ballroom.
Exhibit ballroom will be open during conference hours from:
Thursday, April 20, 2017: 7:30 AM - 8:00 PM
Friday, April 21, 2017: 7:30 AM - 6:30 PM
Saturday, April 22, 2017: 7:30 AM - 1:50 PM
GOLD RUSH BALLROOM, HOLIDAY INN GOLDEN GATEWAY
All sponsored breakfast and lunch sessions as well as 18 tabletop exhibits, coffee breaks, poster reception and e-Posters will be held in the 5,400 square foot Gold Rush Ballroom and its foyer. The CME Sessions as well as the Immuno-oncology CRO Prespective and the Industry - Regulatory - Academic Town Hall Non-CME Educational Sessions will be held directly above the Gold Rush Ballroom in the 5,600 square foot Emerald Ballroom.
Potent ial Lunch or Breakfast Industry Sponsored Session Topics of interest to the Organizing Commit tee:
- Novel Imaging Modalit ies for Sentinel Lymph Node Identif ication and Resection RESERVED LUNCH
- Regional Therapies in Melanoma- Metastatic Biomarker Discovery LUNCH SESSION
SPONSORED BY CASTLE BIOSCIENCES, INC.- Adoptive Cell Therapies- Update on latest clinical trials- Lymphedema Topic
PREMIUM SUPPORT PACKAGES
Platinum Sponsorship: INCLUDES either an unopposed Non-CME Educational Lunch Session including Food & Beverage, meeting room, A/V and digital capture for Virtual Meeting for up to 300 participants OR acknowledgment as sponsors of the Gala Dinner
- AND a tabletop exhibit with up to 4 badges for company reps, - AND acknowledgement of support for 1st, 2nd & 3rd Place Young Investigator OR Trainee Awards - AND e-Poster sponsorship
Total Platinum Sponsorship: $50,000
Gold Sponsorship: INCLUDES either an unopposed Non-CME Educational Breakfast Session including Food & Beverage, meeting room, A/V and digital capture for Virtual Meeting or up to 300 participants OR acknowledgment as sponsors of the Wine & Cheese Poster Reception
- AND a tabletop exhibit with up to 3 badges for company reps, - AND acknowledgement of support for 1st, 2nd & 3rd Place Young Investigator OR Trainee Awards <- AND Logo Memory Sticks with Syllabus, Speaker & e-Poster Presentations
Total Gold Sponsorship: $30,000
Silver sponsorship: INCLUDES acknowledgment as sponsors of 2 sponsored theme coffee breaks OR sponsorship of the unopposed Non-CME Town Hall Session and digital capture for Virtual Meeting (first come first served),
- AND a tabletop exhibit with up to 2 badges for company reps, - AND Wireless Internet for all participants, including a charging station - AND Badge Lanyards
Total Gold Sponsorship: $20,000
INCLUSIVE PREMIUM SUPPORT PACKAGES
SINGLE SUPPORT OPPORTUNITIES: (if not taken by Platinum/Gold/Silver Sponsors)
1. Gala Dinner for up to 400 participants on Friday Evening in China Town, $25,000.2. Unopposed Non-CME Educational Lunch Session, includes food, AV, meeting room up to 300 participants: $25,000. Supporter is
responsible for speaker costs and needs to organize the session in conjunction with a member of the Cancer Metastasis Organizing Committee. Sponsorship includes digitally capturing the session which will be included on the Cancer Metastasis Virtual Meeting at www.cancermetastasis.org (enduring).
3. Unopposed Non-CME Educational Breakfast Session, includes food, AV, meeting room up to 300 participants: $15,000. Supporter is responsible for speaker costs and needs to organize the session in conjunction with a member of the Cancer Metastasis Organizing Committee. Sponsorship includes digitally capturing the session which will be included on the Cancer Metastasis Virtual Meeting at www.cancermetastasis.org (enduring).
4. Wine & Poster Reception for up to 400 participants on Thursday Evening, $15,000 5. Acknowledgement of support e-Poster Technology & Flatscreens (enduring): $15,000 6. Tote Bags, $10,000 7. Wireless Internet for all participants, including a Logo Charging Station, $7,500 8. Logo Memory Sticks with Syllabus, Speaker & e-Poster Presentations & Abstracts (enduring), $5,000 9. Acknowledgement of support of Young Investigator OR Trainee 1st, 2nd and 3rd Place Abstract Awards, $3,00010. Badge Lanyards, $5,000 11. Water Bottles, $5,000 12. Water Cooler, $2,500 13. Acknowledgment as sponsor of one Theme Coffee Break. $3,500 14. Tote Bag Inserts, $750 15. Acknowledgement of support of the Virtual Meeting, digital capture of most presentations (speaker permitted), $10,000 16. Acknowledgement of support of the Mobile App, $3,000
SINGLE ITEM SUPPORT
Along with other benefits of associating with this premier academic conference that follows the journey of cancer metastasis from detection at the molecular level to genomic identification to precision treatment & survival, all supporting companies will receive a dedicated page on www.cancermetastasis.org, to include information such as:
- Company profile, website link, logo- Pictures- Documents, open access manuscripts- Videos- Presentations- Brochures- Other relevant information of interest to participants of Cancer Metastasis 2017- Inclusion in the Symposium Social Media (Facebook, LinkedIn and Twitter).
Other benefits of support:
- Logo to be included on signage near the Exhibit Hall Entrance and on specific items that are being supported;- Acknowledgement in the Symposium Final Program on USB & the Schedule at a Glance - Use of Symposium logo for supporter?s own promotional purposes (must be approved by the Organizing Committee); - Pre & post registration lists identifying attendees names, affiliations & addresses (not applicable for Tote Bag Insert Item).- Assistance with registration at sponsored sessions. - Continued presence on www.cancermetastasis.org Virtual Meeting.
Please contact Joan Oefner at [email protected] to discuss your ideas for a customized support package that would best fit the needs of your company. The Cancer Metastasis through the Lymphovascular System: Biology & Treatment, 7th International Symposium is sponsored by the Sentinel Node Oncology Foundation which is incorporated as a 501 (c) 3 non-profit organization. Tax ID is 20-0173930.